BMAL2 and prostate carcinoma: Importantly, two key circadian‐regulating transcription factors, Bmal2 and Rev‐erbβ (Figures 2A–D and 3), exhibited upregulated expression patterns in TGMAP tumors throughout the 12‐h light/dark cycles, suggesting their potential roles in the growth of advanced prostate cancer.